“The revision to stable reflects MaineHealth’s better-than-anticipated financial performance in 2014 and 2015 coupled with its strong enterprise profile,” said S&P credit analyst Cynthia Keller. “We expect MaineHealth’s increasingly centralized operations and local consolidation efforts will stabilize, and perhaps improve, future financial performance.”
S&P also affirmed the “A+” rating on MaineHealth’s series 2014 revenue bonds, affecting $85 million.
More articles on healthcare finance:
7 recent hospital outlook and credit rating actions
Price tag for UC San Diego specialty hospital approaches $1B
CMS finalizes ACA rule on Medicaid prescription drug rebates, reimbursements
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
